chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Condition aggravated, Dizziness, Erythema, Fatigue
Clinical narrative: Dizziness even worse; Balance problem even worse; Normal problems seem to be intensified; Does not feel as normal; Arm was a little warm; Arm was a little red; So tired that she fell asleep for 2 hour; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness even worse), BALANCE DISORDER (Balance problem even worse), CONDITION AGGRAVATED (Normal problems seem to be intensified), MALAISE (Does not feel as normal) and FEELING HOT (Arm was a little warm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 038K20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Balance difficulty. Concurrent medical conditions included Dizziness.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (Dizziness even worse), BALANCE DISORDER (Balance problem even worse), CONDITION AGGRAVATED (Normal problems seem to be intensified), MALAISE (Does not feel as normal), FEELING HOT (Arm was a little warm), ERYTHEMA (Arm was a little red) and FATIGUE (So tired that she fell asleep for 2 hour). At the time of the report, DIZZINESS (Dizziness even worse), BALANCE DISORDER (Balance problem even worse), CONDITION AGGRAVATED (Normal problems seem to be intensified), MALAISE (Does not feel as normal), FEELING HOT (Arm was a little warm), ERYTHEMA (Arm was a little red) and FATIGUE (So tired that she fell asleep for 2 hour) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Malaise
Clinical narrative: Dizziness even worse; Balance problem even worse; Normal problems seem to be intensified; Does not feel as normal; Arm was a little warm; Arm was a little red; So tired that she fell asleep for 2 hour; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness even worse), BALANCE DISORDER (Balance problem even worse), CONDITION AGGRAVATED (Normal problems seem to be intensified), MALAISE (Does not feel as normal) and FEELING HOT (Arm was a little warm) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 038K20) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Balance difficulty. Concurrent medical conditions included Dizziness.   On 30-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Feb-2021, the patient experienced DIZZINESS (Dizziness even worse), BALANCE DISORDER (Balance problem even worse), CONDITION AGGRAVATED (Normal problems seem to be intensified), MALAISE (Does not feel as normal), FEELING HOT (Arm was a little warm), ERYTHEMA (Arm was a little red) and FATIGUE (So tired that she fell asleep for 2 hour). At the time of the report, DIZZINESS (Dizziness even worse), BALANCE DISORDER (Balance problem even worse), CONDITION AGGRAVATED (Normal problems seem to be intensified), MALAISE (Does not feel as normal), FEELING HOT (Arm was a little warm), ERYTHEMA (Arm was a little red) and FATIGUE (So tired that she fell asleep for 2 hour) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.   Action taken with mRNA-1273 in response to the events was  not applicable
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Bone pain, Fatigue, Myalgia, Pyrexia
Clinical narrative: High Temperature; Myalgia; OSTEALGIA; Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PYREXIA (High Temperature) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse reaction.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced PYREXIA (High Temperature). At the time of the report, PYREXIA (High Temperature) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Swelling of the left side of her face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling of the left side of her face) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025AQ1A) for COVID-19 vaccination.     Concomitant products included METFORMIN for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced SWELLING FACE (Swelling of the left side of her face). On 26-Feb-2021, SWELLING FACE (Swelling of the left side of her face) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Carpal tunnel syndrome, Erythema, Headache
Clinical narrative: sore arm; arm is red; back pain; carpel tunnel pain; a pain from his wrist all the way to his forearm; blurry vision; little swollen arm; joint soreness; headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ROSUVASTATIN, FINASTERIDE and AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling, Vision blurred
Clinical narrative: sore arm; arm is red; back pain; carpel tunnel pain; a pain from his wrist all the way to his forearm; blurry vision; little swollen arm; joint soreness; headache; This spontaneous case was reported by a consumer and describes the occurrence of   in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ROSUVASTATIN, FINASTERIDE and AZILSARTAN MEDOXOMIL, CHLORTALIDONE (EDARBYCLOR) for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Fatigue, Pain in extremity, Pruritus, Swelling
Clinical narrative: Soreness; Swelling; Redness; Itchiness; Fatigued or exhausted after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Soreness), SWELLING (Swelling), ERYTHEMA (Redness), PRURITUS (Itchiness) and FATIGUE (Fatigued or exhausted after getting the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Rash (Rash that has been coming before getting vaccine). Concomitant products included ROPINIROLE and MORPHINE for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Soreness), SWELLING (Swelling), ERYTHEMA (Redness), PRURITUS (Itchiness) and FATIGUE (Fatigued or exhausted after getting the vaccine). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency; CAMPHOR, MENTHOL (SARNA [CAMPHOR;MENTHOL]) at a dose of anti-itch lotion (atopical creams); CORTISONE at an unspecified dose and frequency and COCONUT OIL at a dose of Coconut oil bath. At the time of the report, PAIN IN EXTREMITY (Soreness), SWELLING (Swelling), ERYTHEMA (Redness), PRURITUS (Itchiness) and FATIGUE (Fatigued or exhausted after getting the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter said that she is calling back to provide a fax and email. Prefers to be contacted via email.   Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow up received: No new information.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Nausea
Clinical narrative: Sore arm; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (Sore arm) and NAUSEA (Nauseous) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included COPD (Is on oxygen) and Neurological disorder NOS.   On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 01-Mar-2021, the patient experienced AXILLARY PAIN (Sore arm) and NAUSEA (Nauseous).   The patient was treated with ONDANSETRON HYDROCHLORIDE DIHYDRATE (ZOFRAN [ONDANSETRON HYDROCHLORIDE DIHYDRATE]) at an unspecified dose and frequency.   On 02-Mar-2021, AXILLARY PAIN (Sore arm) and NAUSEA (Nauseous) had resolved.      Concomitant product use was not provided by the reporter.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on legs; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (Rash on legs) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced RASH (Rash on legs). The patient was treated with CEFALEXIN MONOHYDRATE (KEFLEX [CEFALEXIN MONOHYDRATE]) on 02-Mar-2021 for Rash on leg, at an unspecified dose and frequency. At the time of the report, RASH (Rash on legs) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Patient had a rash on the front of both legs, which was spreading. After 2 weeks, rash on left leg went. A week before the second dose, the rash on the right leg moved from the front to the back. Patient received her second dose on 02-MAR-2021 and on the same day her physician prescribed Cefalexin as treatment.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Confusional state, Fatigue, Feeling abnormal, Feeling cold
Clinical narrative: They could not think clear; Brain fog; Did not feel themselves; Felt confusion in their brain; Their arm was really sore; Feeling very cold; Unrelated left hand injury; Body pain; Feeling tired; Chills; Muscle Aches; This spontaneous case was reported by a consumer and describes the occurrence of THINKING ABNORMAL (They could not think clear), FEELING ABNORMAL (Brain fog), FEELING ABNORMAL (Did not feel themselves), CONFUSIONAL STATE (Felt confusion in their brain) and PAIN IN EXTREMITY (Their arm was really sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sleep problem and Anxiety. Concomitant products included CLONAZEPAM for Anxiety, TRAZODONE for Sleep problem.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced THINKING ABNORMAL (They could not think clear), FEELING ABNORMAL (Brain fog), FEELING ABNORMAL (Did not feel themselves), CONFUSIONAL STATE (Felt confusion in their brain), PAIN IN EXTREMITY (Their arm was really sore), FEELING COLD (Feeling very cold), LIMB INJURY (Unrelated left hand injury), PAIN (Body pain), FATIGUE (Feeling tired), CHILLS (Chills) and MYALGIA (Muscle Aches). At the time of the report, THINKING ABNORMAL (They could not think clear), FEELING ABNORMAL (Brain fog), FEELING ABNORMAL (Did not feel themselves), CONFUSIONAL STATE (Felt confusion in their brain), PAIN IN EXTREMITY (Their arm was really sore), FEELING COLD (Feeling very cold), LIMB INJURY (Unrelated left hand injury), PAIN (Body pain), FATIGUE (Feeling tired), CHILLS (Chills) and MYALGIA (Muscle Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient felt a brain fog, they could not think clear, felt like high on drugs or something, did not feel themselves, felt confusion in their brain, and it was unsettling, they did not like the feeling, their brain was fuzz like a fog, a really odd feeling that lasted for 48 hours.  Treatment for the events included  using heating pad and hot bath.   This case was linked to MOD-2021-066907 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Limb injury, Myalgia, Pain, Pain in extremity, Thinking abnormal
Clinical narrative: They could not think clear; Brain fog; Did not feel themselves; Felt confusion in their brain; Their arm was really sore; Feeling very cold; Unrelated left hand injury; Body pain; Feeling tired; Chills; Muscle Aches; This spontaneous case was reported by a consumer and describes the occurrence of THINKING ABNORMAL (They could not think clear), FEELING ABNORMAL (Brain fog), FEELING ABNORMAL (Did not feel themselves), CONFUSIONAL STATE (Felt confusion in their brain) and PAIN IN EXTREMITY (Their arm was really sore) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sleep problem and Anxiety. Concomitant products included CLONAZEPAM for Anxiety, TRAZODONE for Sleep problem.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced THINKING ABNORMAL (They could not think clear), FEELING ABNORMAL (Brain fog), FEELING ABNORMAL (Did not feel themselves), CONFUSIONAL STATE (Felt confusion in their brain), PAIN IN EXTREMITY (Their arm was really sore), FEELING COLD (Feeling very cold), LIMB INJURY (Unrelated left hand injury), PAIN (Body pain), FATIGUE (Feeling tired), CHILLS (Chills) and MYALGIA (Muscle Aches). At the time of the report, THINKING ABNORMAL (They could not think clear), FEELING ABNORMAL (Brain fog), FEELING ABNORMAL (Did not feel themselves), CONFUSIONAL STATE (Felt confusion in their brain), PAIN IN EXTREMITY (Their arm was really sore), FEELING COLD (Feeling very cold), LIMB INJURY (Unrelated left hand injury), PAIN (Body pain), FATIGUE (Feeling tired), CHILLS (Chills) and MYALGIA (Muscle Aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient felt a brain fog, they could not think clear, felt like high on drugs or something, did not feel themselves, felt confusion in their brain, and it was unsettling, they did not like the feeling, their brain was fuzz like a fog, a really odd feeling that lasted for 48 hours.  Treatment for the events included  using heating pad and hot bath.   This case was linked to MOD-2021-066907 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Nausea
Clinical narrative: had ice cream again today and was feeling nauseous; had ice cream yesterday and had a bad upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (had ice cream yesterday and had a bad upset stomach) and NAUSEA (had ice cream again today and was feeling nauseous) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (hand). Concomitant products included PARACETAMOL (TYLENOL) for Surgery.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (had ice cream yesterday and had a bad upset stomach). On 04-Mar-2021, the patient experienced NAUSEA (had ice cream again today and was feeling nauseous). At the time of the report, ABDOMINAL DISCOMFORT (had ice cream yesterday and had a bad upset stomach) and NAUSEA (had ice cream again today and was feeling nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medications was not provided by the reporter   This case was linked to MOD21-044476 (Patient Link).
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site induration, Vaccination site inflammation
Clinical narrative: Inflammation and hardness to filler areas; Inflammation and hardness to filler areas; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflammation and hardness to filler areas) and VACCINATION SITE INDURATION (Inflammation and hardness to filler areas) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: VARICELLA ZOSTER VACCINE (Patient had Restylane-L injected to upper cheeks on 18-Jun-2020.) on 17-Aug-2020.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE INFLAMMATION (Inflammation and hardness to filler areas) and VACCINATION SITE INDURATION (Inflammation and hardness to filler areas). At the time of the report, VACCINATION SITE INFLAMMATION (Inflammation and hardness to filler areas) and VACCINATION SITE INDURATION (Inflammation and hardness to filler areas) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Additional Info Non Significant Followup
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Cough, Myalgia, Pain in extremity, Productive cough
Clinical narrative: Loose cough (getting to be more productive); Sneezing; Dry cough; Sore arm; Hip Pain; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), COUGH (Dry cough), PRODUCTIVE COUGH (Loose cough (getting to be more productive)), SNEEZING (Sneezing) and ARTHRALGIA (Hip Pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (Hip Pain) and MYALGIA (Muscle aches). On 26-Feb-2021, the patient experienced COUGH (Dry cough). On 02-Mar-2021, the patient experienced PRODUCTIVE COUGH (Loose cough (getting to be more productive)) and SNEEZING (Sneezing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) ongoing since an unknown date at an unspecified dose and frequency. On 26-Feb-2021, PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (Hip Pain) and MYALGIA (Muscle aches) had resolved. At the time of the report, COUGH (Dry cough), PRODUCTIVE COUGH (Loose cough (getting to be more productive)) and SNEEZING (Sneezing) outcome was unknown.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-032313 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Sneezing
Clinical narrative: Loose cough (getting to be more productive); Sneezing; Dry cough; Sore arm; Hip Pain; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), COUGH (Dry cough), PRODUCTIVE COUGH (Loose cough (getting to be more productive)), SNEEZING (Sneezing) and ARTHRALGIA (Hip Pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (Hip Pain) and MYALGIA (Muscle aches). On 26-Feb-2021, the patient experienced COUGH (Dry cough). On 02-Mar-2021, the patient experienced PRODUCTIVE COUGH (Loose cough (getting to be more productive)) and SNEEZING (Sneezing). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) ongoing since an unknown date at an unspecified dose and frequency and DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PARACETAMOL, PSEUDOEPHEDRINE HYDROCHLORIDE (DAYQUIL) ongoing since an unknown date at an unspecified dose and frequency. On 26-Feb-2021, PAIN IN EXTREMITY (Sore arm), ARTHRALGIA (Hip Pain) and MYALGIA (Muscle aches) had resolved. At the time of the report, COUGH (Dry cough), PRODUCTIVE COUGH (Loose cough (getting to be more productive)) and SNEEZING (Sneezing) outcome was unknown.            No relevant concomitant medications were reported.   This case was linked to MOD-2021-032313 (Patient Link).
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Dyspnoea, Feeling cold, Migraine
Clinical narrative: Feeling very cold; Anxiety / Covid19 symptoms similar to anxiety; Hands cold feel like ice packs; Trembling / little shaking; Twitching; Shortness of breath; Migraine; Fever 96 F, 98 F, then 96.6 F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 215M20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included LORAZEPAM, LEVOTHYROXINE, MAGNESIUM GLYCINATE, PARACETAMOL (TYLENOL EXTRA STRENGTH), CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), FISH OIL, VITAMIN B12 [VITAMIN B12 NOS], VITAMIN B2 [RIBOFLAVIN] and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). On 02-Mar-2021, CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle twitching, Peripheral coldness, Pyrexia, Tremor
Clinical narrative: Feeling very cold; Anxiety / Covid19 symptoms similar to anxiety; Hands cold feel like ice packs; Trembling / little shaking; Twitching; Shortness of breath; Migraine; Fever 96 F, 98 F, then 96.6 F; Chills; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 215M20A) for COVID-19 vaccination.     No reported medical history.  Concomitant products included LORAZEPAM, LEVOTHYROXINE, MAGNESIUM GLYCINATE, PARACETAMOL (TYLENOL EXTRA STRENGTH), CALCIUM CARBONATE (CALTRATE [CALCIUM CARBONATE]), FISH OIL, VITAMIN B12 [VITAMIN B12 NOS], VITAMIN B2 [RIBOFLAVIN] and ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills). On 02-Mar-2021, CHILLS (Chills) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Aphonia
Clinical narrative: lost her voice completely at night; This spontaneous case was reported by a consumer and describes the occurrence of APHONIA (lost her voice completely at night) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced APHONIA (lost her voice completely at night). The patient was treated with PARACETAMOL (TYLENOL) for Adverse reaction, at a dose of 1 dosage form and LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse reaction, at a dose of 1 dosage form. At the time of the report, APHONIA (lost her voice completely at night) outcome was unknown.            No concomitant medications reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 38-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21a) for COVID-19 vaccination.     Concurrent medical conditions included Ex-alcohol user. Concomitant products included IRON for Anemia, MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 29-Aug-2020 and the estimated date of delivery was 31-May-2021. On 28-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy.  At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Sep-2020, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that when she received her first shot she was 26 weeks and 6 days. On 28 Sep 2020 she had positive pregnancy test. Estimated date of conception was 2020. Ultrasound was performed on 09 Nov 2020 when patient was 10 weeks pregnant and on 11 Jan 2021 were normal. She had 2 previous pregnancies, one on 17 Dec 2016 and other on 22 Oct 2018 both where live and full-term birth.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Nausea
Clinical narrative: noticed the nausea significantly today; had ice cream yesterday and had upset stomach; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (had ice cream yesterday and had upset stomach) and NAUSEA (noticed the nausea significantly today) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A214) for COVID-19 vaccination.     Concurrent medical conditions included HIV disease. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced ABDOMINAL DISCOMFORT (had ice cream yesterday and had upset stomach). On 03-Mar-2021, the patient experienced NAUSEA (noticed the nausea significantly today). At the time of the report, ABDOMINAL DISCOMFORT (had ice cream yesterday and had upset stomach) and NAUSEA (noticed the nausea significantly today) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's medical history included HIV and underlying conditions.  Treatment medications was not provided by the reporter
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Injection site pain
Clinical narrative: Diarrhea; loss appetite; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DECREASED APPETITE (loss appetite) and INJECTION SITE PAIN (injection site pain) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (tested COVID-19 positive).    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced DECREASED APPETITE (loss appetite) and INJECTION SITE PAIN (injection site pain). On 02-Mar-2021, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Adverse reaction, at a dose of 1 dosage form and IBUPROFEN (ADVIL 12HOUR) on 27-Feb-2021 for Adverse reaction, at a dose of 2 dosage form. On 28-Feb-2021, INJECTION SITE PAIN (injection site pain) had resolved. At the time of the report, DIARRHOEA (Diarrhea) and DECREASED APPETITE (loss appetite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Blood glucose increased
Clinical narrative: Blood sugar level higher than normal (340); This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)). The patient was treated with INSULIN ASPART (INSULINE ASPARTATE) ongoing since an unknown date for Blood sugar increased, at an unspecified dose and frequency. At the time of the report, BLOOD GLUCOSE INCREASED (Blood sugar level higher than normal (340)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Blood glucose: 340 (High) more than normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.  Treatment for the event included injectable insulin.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Loss of appetite; Itching at rash; Big red rash at site of injection which is 6 inches long and 4 inches wide; Big red rash at site of injection which is 6 inches long and 4 inches wide; Rash hurt; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), VACCINATION SITE PRURITUS (Itching at rash), VACCINATION SITE ERYTHEMA (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE RASH (Big red rash at site of injection which is 6 inches long and 4 inches wide) and VACCINATION SITE PAIN (Rash hurt) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 13L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), VACCINATION SITE PRURITUS (Itching at rash), VACCINATION SITE ERYTHEMA (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE RASH (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE PAIN (Rash hurt) and FATIGUE (Tiredness). At the time of the report, DECREASED APPETITE (Loss of appetite), VACCINATION SITE PRURITUS (Itching at rash), VACCINATION SITE ERYTHEMA (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE RASH (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE PAIN (Rash hurt) and FATIGUE (Tiredness) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site rash
Clinical narrative: Loss of appetite; Itching at rash; Big red rash at site of injection which is 6 inches long and 4 inches wide; Big red rash at site of injection which is 6 inches long and 4 inches wide; Rash hurt; Tiredness; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Loss of appetite), VACCINATION SITE PRURITUS (Itching at rash), VACCINATION SITE ERYTHEMA (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE RASH (Big red rash at site of injection which is 6 inches long and 4 inches wide) and VACCINATION SITE PAIN (Rash hurt) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 13L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced DECREASED APPETITE (Loss of appetite), VACCINATION SITE PRURITUS (Itching at rash), VACCINATION SITE ERYTHEMA (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE RASH (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE PAIN (Rash hurt) and FATIGUE (Tiredness). At the time of the report, DECREASED APPETITE (Loss of appetite), VACCINATION SITE PRURITUS (Itching at rash), VACCINATION SITE ERYTHEMA (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE RASH (Big red rash at site of injection which is 6 inches long and 4 inches wide), VACCINATION SITE PAIN (Rash hurt) and FATIGUE (Tiredness) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Three weeks after first shot, the shingles appeared; This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Three weeks after first shot, the shingles appeared) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: VARICELLA ZOSTER VACCINE (when patient was 60 (15 years ago)).    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (Three weeks after first shot, the shingles appeared). At the time of the report, HERPES ZOSTER (Three weeks after first shot, the shingles appeared) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Blood test, Decreased appetite, Pyrexia, SARS-CoV-2 test
Clinical narrative: on and off with fever; back pain; loss of appetite which made patient loss 12 pounds; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (on and off with fever), BACK PAIN (back pain) and DECREASED APPETITE (loss of appetite which made patient loss 12 pounds) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PYREXIA (on and off with fever), BACK PAIN (back pain) and DECREASED APPETITE (loss of appetite which made patient loss 12 pounds). The patient was treated with IBUPROFEN ongoing since an unknown date for Fever, at a dose of 2 dosage form twice a day. At the time of the report, PYREXIA (on and off with fever), BACK PAIN (back pain) and DECREASED APPETITE (loss of appetite which made patient loss 12 pounds) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal. On an unknown date, SARS-CoV-2 test: normal (normal) Normal. On an unknown date, Urine analysis: normal (normal) Normal. On an unknown date, X-ray: normal (normal) Normal.
Sex: M
Vaccine: COVID19
Symptoms: Urine analysis, X-ray
Clinical narrative: on and off with fever; back pain; loss of appetite which made patient loss 12 pounds; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (on and off with fever), BACK PAIN (back pain) and DECREASED APPETITE (loss of appetite which made patient loss 12 pounds) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 28-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced PYREXIA (on and off with fever), BACK PAIN (back pain) and DECREASED APPETITE (loss of appetite which made patient loss 12 pounds). The patient was treated with IBUPROFEN ongoing since an unknown date for Fever, at a dose of 2 dosage form twice a day. At the time of the report, PYREXIA (on and off with fever), BACK PAIN (back pain) and DECREASED APPETITE (loss of appetite which made patient loss 12 pounds) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: normal (normal) Normal. On an unknown date, SARS-CoV-2 test: normal (normal) Normal. On an unknown date, Urine analysis: normal (normal) Normal. On an unknown date, X-ray: normal (normal) Normal.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Ear pain, Headache, Myalgia, Nausea
Clinical narrative: body aches; headache; pain in the ears; fever of 101.8 F; Nausea; sore arm; dizzy; "synapse" pressure; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), HEADACHE (headache), EAR PAIN (pain in the ears), PYREXIA (fever of 101.8 F) and NAUSEA (Nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced MYALGIA (body aches), HEADACHE (headache), EAR PAIN (pain in the ears), PYREXIA (fever of 101.8 F), NAUSEA (Nausea), PAIN IN EXTREMITY (sore arm), DIZZINESS (dizzy) and PARANASAL SINUS DISCOMFORT ("synapse" pressure). At the time of the report, MYALGIA (body aches), HEADACHE (headache), EAR PAIN (pain in the ears), PYREXIA (fever of 101.8 F), NAUSEA (Nausea), PAIN IN EXTREMITY (sore arm), DIZZINESS (dizzy) and PARANASAL SINUS DISCOMFORT ("synapse" pressure) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paranasal sinus discomfort, Pyrexia
Clinical narrative: body aches; headache; pain in the ears; fever of 101.8 F; Nausea; sore arm; dizzy; "synapse" pressure; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), HEADACHE (headache), EAR PAIN (pain in the ears), PYREXIA (fever of 101.8 F) and NAUSEA (Nausea) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 immunization. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced MYALGIA (body aches), HEADACHE (headache), EAR PAIN (pain in the ears), PYREXIA (fever of 101.8 F), NAUSEA (Nausea), PAIN IN EXTREMITY (sore arm), DIZZINESS (dizzy) and PARANASAL SINUS DISCOMFORT ("synapse" pressure). At the time of the report, MYALGIA (body aches), HEADACHE (headache), EAR PAIN (pain in the ears), PYREXIA (fever of 101.8 F), NAUSEA (Nausea), PAIN IN EXTREMITY (sore arm), DIZZINESS (dizzy) and PARANASAL SINUS DISCOMFORT ("synapse" pressure) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Chills, Cough, Malaise, Pyrexia
Clinical narrative: hasn't real felt well; cough; fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (hasn't real felt well), COUGH (cough), PYREXIA (fever) and CHILLS (chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Gout, Arthritis and Cholesterol.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MALAISE (hasn't real felt well), COUGH (cough), PYREXIA (fever) and CHILLS (chills). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for Adverse reaction, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Adverse reaction, at a dose of 1 dosage form. At the time of the report, MALAISE (hasn't real felt well), COUGH (cough), PYREXIA (fever) and CHILLS (chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Body temperature: 101.4 (High) fever.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications included unspecified medicines for high blood pressure, gout, arthritis and cholesterol.
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Pain in extremity
Clinical narrative: sore arm; bruised arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm) and CONTUSION (bruised arm) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 25-Feb-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and CONTUSION (bruised arm).        For mRNA-1273 (Moderna COVID-19 Vaccine), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-028726 (Patient Link).   Reporter did not allow further contact